Prolia enters range of health insurance benefits based on excellent bone density improvement

Published: 2017-10-10 16:27:00
Updated: 2017-10-10 14:05:00

‘Prolia(generic name: denosumab),’ an Amgen Korea’s first biological osteoporosis treatment, has been registered in the health insurance benefit list since the 1st of October.

Prolia, the first and only osteoporosis treatment targeting RANKL, is a once-6-month hypodermic injection. After launche...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.